چكيده به لاتين
A unique feature of the pharmaceutical industry such as economic and trade aspects and Effect of intervention in one of the other parts of the health to make up the process in order to do a more detailed review and analysis of influencing factors On commercialization of new technologies and formulations therefore have been in this industry due to restrictions. Try to share that with regard to the use of technology in the pharmaceutical industry with pharmaceutical companies and facilitate the commercialization of research and development and then restore fair drug prices for consumers and producers (to maintain a competitive advantage) is obtained.
Lack of access to adequate financial and human resources is one of the country's pharmaceutical system damage. Currently less than six percent of pharmacists working in the pharmaceutical industry. In addition, a significant portion of activists associated with the pharmaceutical industry do not have the training and expertise. Lack of access to financial resources, monetary and foreign countries for the pharmaceutical industry, especially in recent years And thus does not provide reconstruction and infrastructure in production lines for the production of new drugs cause The backwardness of the industry's global pharmaceutical development. The result is that the pharmaceutical industry because the country is not able to produce new drugs and high-tech , produce low value-added are old drugs, The result is a significant reduction in the share of domestic production in the country's pharmaceutical market. On the other hand there is heavy debts, public health centers, pharmaceutical companies, the limited financial resources available to them.
In this thesis, by taking both open innovation and commercialization of technology as effectively as key drivers, try to provide a model for efficiency in the pharmaceutical industry to design early market. In line with this model, indicators of innovation, technology and the market return soon also explained that influence market design. These indicators mainly from the literature, medicines agencies to study documents and interviews with experts in the field have been obtained. The final parameters using confirmatory factor analysis screening has been confirmed.
Keywords: pharmaceutical industry, open innovation, commercialization, confirmatory factor analysis, research and development.